Company Biography
Developing a new cell and gene therapy is rewarding but there are unique challenges ahead. We're here to help. With 30+ years of gene therapy experience we bring expertise in viral vector manufacturing and testing as well as a global organization to integrate regulatory, safety, and process development to fit your needs. Draw on our experience to help overcome your challenges and speed your therapy to patients.
And beyond cell and gene therapy, our comprehensive life science portfolio supports customers during all stages of the drug manufacturing process. We offer a broad range of products and services including single-use manufacturing, filtration, chromatography and purification, virus reduction, pharma and biopharma raw materials, drug delivery compounds, and engineering and validation services.
Please visit us: www.emdmillipore.com
Efficient DNA Clearance: Better, Faster Virus Production
Innovation - Merck
What is Convergent BioProcessing? - Merck
Innovation - MSIG
What is Convergent Bioprocessing - MSIG
Contact Information
Team Members
Delphine Gilbert
European Trade Show Project Manager
Amy LaRocca
MilliporeSigma
Event Specialist - Americas
Paul Beckett
Merck
Sr. Technology Manager - Purification
Carl Ahuja
Merck
Sr. Sales Development Specialist Emerging Biotech
Clothilde Decarnin
Merck
Purification Technology Manager
Maxwell Paluszynski
MilliporeSigma
Associate Segment Manager, Cell and Gene Therapy – Bioprocessing
Youness Cherradi
Merck
EMEA Senior Process Development Scientist, Technology Management
Jennifer Campbell
Merck
Upstream Technical Specialist
Joshua Hays
MilliporeSigma
Associate Director of Commercial Strategy - BioContinuum Platform